Researchers proved that the simultaneous interaction of these molecules reduced metastatic dissemination of lung cancer cells both in vitro and in vivo through CXCR4 (C-X-C Motif Chemokine Receptor 4) inhibition. The gene discussed is CXCR4; the disease is lung cancer.